Description

THYROACTIVE 25 MG (1X100)

Indications

THYROACTIVE 25 MG is primarily indicated for the treatment of hypothyroidism, a condition characterized by insufficient production of thyroid hormones. It is also used in the management of goiter and as part of the therapeutic regimen for certain types of thyroid cancer. Patients with congenital hypothyroidism may also benefit from this medication, which helps restore normal thyroid hormone levels, thereby improving metabolic functions and overall health.

Mechanism of Action

THYROACTIVE contains levothyroxine sodium, a synthetic form of thyroxine (T4), which is a hormone produced by the thyroid gland. Once administered, levothyroxine is converted into its active form, triiodothyronine (T3), in peripheral tissues. These hormones play a crucial role in regulating metabolism, growth, and development. They exert their effects by binding to thyroid hormone receptors in various tissues, leading to increased protein synthesis, enhanced glucose metabolism, and improved lipid metabolism, which collectively contribute to the maintenance of normal physiological functions.

Pharmacological Properties

THYROACTIVE is well-absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within 2 to 4 hours after oral administration. The drug has a half-life of approximately 7 days, allowing for once-daily dosing in most cases. Levothyroxine is highly protein-bound, primarily to thyroxine-binding globulin (TBG), albumin, and transthyretin. The pharmacodynamics of THYROACTIVE are characterized by its ability to increase the basal metabolic rate, enhance oxygen consumption, and stimulate the metabolism of carbohydrates, fats, and proteins.

Contraindications

THYROACTIVE is contraindicated in patients with known hypersensitivity to levothyroxine or any of its excipients. It should not be used in individuals with untreated adrenal insufficiency, as this may precipitate an adrenal crisis. Additionally, patients with thyrotoxicosis or those who have recently had a myocardial infarction should avoid this medication, as it may exacerbate these conditions.

Side Effects

Common side effects of THYROACTIVE may include weight loss, increased appetite, nervousness, insomnia, and heat intolerance. More serious adverse effects can occur, such as palpitations, tachycardia, and hypertension, particularly in patients receiving excessive doses. Allergic reactions, though rare, may manifest as rash, itching, or swelling. Patients should be advised to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The dosage of THYROACTIVE is individualized based on the patient’s age, weight, and clinical response. For adults with hypothyroidism, the typical starting dose is 1.6 mcg/kg/day, which may be adjusted based on serum TSH levels. For elderly patients or those with underlying cardiovascular conditions, a lower starting dose of 12.5 to 25 mcg/day may be recommended. It is crucial to take THYROACTIVE on an empty stomach, ideally 30 to 60 minutes before breakfast, to enhance absorption. Patients should be advised to take the medication consistently at the same time each day.

Interactions

THYROACTIVE may interact with several medications and substances. Antacids, calcium supplements, and iron preparations can decrease the absorption of levothyroxine, necessitating a separation of dosing by at least four hours. Certain medications, such as anticoagulants, may have their effects potentiated by levothyroxine, requiring careful monitoring of coagulation parameters. Additionally, drugs that affect thyroid hormone metabolism, such as rifampin and phenytoin, may necessitate dosage adjustments of THYROACTIVE.

Precautions

Patients with a history of cardiovascular disease, such as coronary artery disease or hypertension, should be closely monitored while on THYROACTIVE, as the medication can increase heart rate and blood pressure. Regular monitoring of thyroid function tests is essential to ensure that the dosage remains within the therapeutic range. Pregnant women should also be monitored closely, as thyroid hormone requirements may increase during pregnancy. It is important for patients to inform their healthcare provider of any other medications they are taking, as well as any pre-existing health conditions.

Clinical Studies

Clinical studies have demonstrated the efficacy of levothyroxine in restoring normal thyroid function in patients with hypothyroidism. A randomized controlled trial published in the Journal of Clinical Endocrinology & Metabolism showed that patients treated with levothyroxine experienced significant improvements in symptoms and quality of life compared to those receiving a placebo. Furthermore, long-term studies indicate that appropriate levothyroxine therapy can reduce the risk of cardiovascular events in patients with hypothyroidism. These findings underscore the importance of individualized treatment plans and regular monitoring of thyroid function.

Conclusion

THYROACTIVE 25 MG is an effective treatment option for patients with hypothyroidism and other thyroid-related conditions. Its active ingredient, levothyroxine, works by restoring normal thyroid hormone levels, thereby improving metabolic processes and overall health. However, careful consideration of contraindications, potential side effects, and drug interactions is essential for safe and effective use. Regular monitoring and dosage adjustments are critical to achieving optimal therapeutic outcomes.